葡萄膜炎并发白内障术后前房注射地塞米松的疗效观察

目的:探索白内障摘除术后前房注射0.1mL地塞米松对葡萄膜炎并发白内障患者术后的影响。方法:试验组术后前房注射0.1mL地塞米松,对照组前房未注射地塞米松,观察两组术后炎症反应。结果:术后前2d两组患者视力间差别有统计学意义(P<0.05),术后第1d角膜水肿程度两组间有统计学差异(P<0.05),前房闪辉差异有统计学意义(P<0.05),且试验组术后患者视力提高者百分比高于对照组。结论:葡萄膜炎并发白内障患者行白内障超声乳化+人工晶状体植入术,术毕前房注射0.1mL地塞米松者可减轻短期术后炎症反应,可更早提高患者视力,对患者术后短期眼压未见明显影响。

Clinical research on anterior chamber injection of dexamethasone after cataract surgery with uveitis

AIM:To explore cataract surgery complication of the anterior chamber injection 0.1mL dexamethasone for uveitis complicated cataract patients.

METHODS: The experimental group was injected 0.1mL dexamethasone to anterior chamber at the end of phacoemulsification(Phaco)+intraocular lens(IOL)implantation, while the control group did not. And the different postoperative inflammation between them was observed.

RESULTS: The differences of visual acuity between the two groups on the first two days after operation were statistically significant(P<0.05). The postoperative corneal edema and anterior chamber flare between the two groups in the first day were different(P<0.05). And the percentage of the experimental group postoperative visual acuity improved was higher than that of the control group.

CONCLUSION: It can reduce short-term postoperative inflammation, improve visual acuity earlier and do not impact the short-term postoperative intraocular pressure that uveitis complicated cataract was injected 0.1mL dexamethasone to anterior chamber at the end of Phaco+IOL.